Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma

Expert Opinion on Therapeutic Targets

Volumn 16, Issue SUPPL. 1, 2012, Pages

  Verma, Mohit Kumar ^a   Miki, Yasuhiro ^a   Abe, Keiko ^a   Niikawa, Hiromichi ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aromatase; Estrogen receptor; Lung carcinoma; MAPK inhibitor; Non genomic

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AROMATASE; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT; GEFITINIB; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR MARKER;

ADULT; AGED; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME;

AROMATASE; BUTADIENES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CYTOPLASM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NITRILES; TUMOR MARKERS, BIOLOGICAL;

EID: 84857524622     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2011.630664     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108 (Pubitemid 40372904)
2. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2:506-13 (Pubitemid 33586306)
3. Canver CC, Memoli VA, Vanderveer PL, et al. Sex hormone receptors in non-small-cell lung cancer in human beings. J Thorac Cardiovasc Surg 1994;108:153-7 (Pubitemid 24224271)
4. Omoto Y, Kobayashi Y, Nishida K, et al. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun 2001;285:340-7 (Pubitemid 32918076)
5. Schwartz G, Prysak GM, Murphy V, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005;11:7280-7 (Pubitemid 41507685)
6. Stabile LP, Lyker JS, Gubish CT, et al. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005;65:1459-70 (Pubitemid 40270175)
7. Marquez-Garban DC, Chen HW, Fishbein MC, et al. Estrogen receptor signalling pathways in human non-small cell lung cancer. Steroids 2007;72:135-43 (Pubitemid 46273500)
8. Bardin A, Boulle N, Lazennec G, et al. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004;11:537-51 (Pubitemid 39331282)
9. Skliris GP, Leygue E, Watson PH, Murphy LC. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target. J Steroid Biochem Mol Biol 2008;109:1-10
10. Matsuyama S, Ohkura Y, Eguchi H, et al. Estrogen receptor beta is expressed in human stomach adenocarcinoma. J Cancer Res Clin Oncol 2002;128:319-24 (Pubitemid 34569353)
11. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ERalpha and ERbeta. Mol Interv 2003;3:281-92
12. Hershberger PA, Stabile LP, Kanterewicz B, et al. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. J Steroid Biochem Mol Biol 2009;116:102-9
13. Hershberger PA, Vasquez AC, Kanterewicz B, et al. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 2005;65:1598-605 (Pubitemid 40270190)
14. Zhang GF, Liu X, Farkas AM, et al. Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells. Mol Endocrinol 2009;23:146-56
15. Pietras RJ, Marquez DC, Chen HW, et al. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 2005;70:372-81 (Pubitemid 40616035)
16. Levin ER. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 2003;17:309-17 (Pubitemid 36315626)
17. Niikawa H, Suzuki T, Suzuki S, et al. Intratumoral estrogens and estrogen receptors in non-small cell lung carcinoma. Clin Cancer Res 2008;14:4417-26
18. Abe K, Miki Y, Sugawara S, et al. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer. Hum Pathol 2010;41:190-8
19. Oyama T, Kagawa N, Sugio K, et al. Expression of aromatase CYP19 and its relationship with parameters in NSCLC. Front Biosci 2009;14:2285-92
20. Mah V, Seligson DB, Li A, et al. Aromatase expression predicts survival in women with early-stage non-small cell lung cancer. Cancer Res 2007;67:10484-90 (Pubitemid 350070824)
21. Weinberg OK, Marquez-Garban DC, Fishbein MC, et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res 2005;65:11287-91 (Pubitemid 41821684)
22. Sasano H, Anderson TJ, Silverberg SG, et al. The validation of new aromatase monoclonal antibodies for immunohistochemistry - a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol 2005;95:35-9 (Pubitemid 41137291)
23. Skov BG, Fischer BM, Pappot H. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer 2008;59:88-94
24. Ishibashi H, Suzuki T, Suzuki S, et al. Progesterone receptor in non-small cell lung cancer - a potent prognostic factor and possible target for endocrine therapy. Cancer Res 2005;65:6450-8 (Pubitemid 40994434)
25. Suzuki T, Miki Y, Moriya T, et al. 5alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer 2007;120:285-891
26. Jordan VC. Selective estrogen receptor modulation: concept and consequences in cancer. Cancer Cell 2004;5:207-13 (Pubitemid 38402112)
27. Verma MK, Miki Y, Sasano H. Aromatase in human lung carcinoma. Steroids 2011;76:759-64
28. Speirs V, Green CA, Shaaban AM. Oestrogen receptor beta immunohistochemistry: time to get it right? J Clin Pathol 2008;61:1150-1
29. Wu CT, Chang YL, Shih JY, Lee YC. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 2005;130:979-86
30. Stabile LP, Dacic S, Land SR, et al. Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Clin Cancer Res 2011;17:154-64
31. Thun MJ, Henley SJ, Burns D, et al. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006;98:691-9 (Pubitemid 43832505)
32. Mah V, Marquez D, Alavi M, et al. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer 2011;74:318-25
33. Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997;277:1508-10 (Pubitemid 27449239)
34. Saville B, Wormke M, Wang F, et al. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 2000;275:5379-87 (Pubitemid 30115168)
35. Langer G, Bader B, Meoli L, et al. LA critical review of fundamental controversies in the field of GPR30 research. Steroids 2010;75:603-10
36. Shen H, Yuan Y, Sun J, et al. Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects. Biomed Pharmacother 2010;64:88-92
37. Lazzara MJ, Lane K, Chan R, et al. Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations. Cancer Res 2010;70:3843-50